Select Medical Q4 2020 Earnings Report
Key Takeaways
Select Medical Holdings Corporation reported a revenue increase of 6.2% to $1,460.5 million for the fourth quarter ended December 31, 2020. Net income increased by 134.1% to $102.2 million, and earnings per share increased to $0.57 on a fully diluted basis.
Revenue increased 6.2% to $1,460.5 million compared to the same quarter prior year.
Income from operations increased 45.4% to $163.3 million.
Net income increased 134.1% to $102.2 million.
Adjusted EBITDA increased 28.7% to $221.3 million.
Select Medical
Select Medical
Select Medical Revenue by Segment
Forward Guidance
Select Medical expects for the full year of 2021 revenue to be in the range of $5.65 billion to $5.85 billion and Adjusted EBITDA for the full year of 2021 to be in the range of $840.0 million to $880.0 million. Select Medical expects fully diluted earnings per common share for the full year 2021 to be in the range of $2.26 to $2.48.
Revenue & Expenses
Visualization of income flow from segment revenue to net income